Role of Altered Intestinal Function in the Protective Effects of Nematode Infection Against the Development of Type 1 Diabetes (T1d) in Non Obese Diabetic (NOD) Mice

被引：0
|
作者：
Notan, Luigi
Yan, Shu
Sun, Rex
Grinchuk, Viktoriya
Stiltz, Jennifer A.
Zhao, Aiping
Smith, Allen
Shea-Donohue, Terez
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [21] Diabetic Kidney Disease (DKD) in UK Patients With Type 1 Diabetes (T1D)
    Ruzafa, Javier Cid
    Paczkowski, Rosirene
    Boye, Kristina S.
    Di Tanna, Gian Luca
    Sheetz, Matthew J.
    Donaldson, Robert
    Breyer, Matthew D.
    Neasham, David
    Voelker, James R.
    DIABETES, 2013, 62 : A694 - A694
  • [22] Exploring the Protective Role of Arm and Leg Fat Against Coronary Artery Disease (CAD) in Men and Women with Type 1 Diabetes (T1D)
    Shay, Christina M.
    Strotmeyer, Elsa M.
    Orchard, Trevor J.
    DIABETES, 2009, 58 : A180 - A180
  • [23] Oral Administration of Synthetic Retinoid Am80 Inhibits the Development of Type 1 Diabetes in Non-obese Diabetic (NOD) Mice
    Miwako, Ishido
    Shudo, Koichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (01) : 157 - 159
  • [24] Interleukin (IL)-16 plays an inflammatory role in the development of insulitis and Type 1 Diabetes (T1D).
    Meagher, TC
    Mi, QS
    Cruikshank, WW
    Arreaza, G
    Chen, W
    Delovitch, TL
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S104 - S104
  • [25] Metabolomic Determinants Associated with a Risk of and Protection against Late Diabetic Nephropathy Progression in Type 1 Diabetes (T1D)
    Niewczas, Monika A.
    Smiles, Adam
    Croall, Stephanie
    Major, Melissa
    Mcdonnell, Kevin
    Krolewski, Andrzej S.
    DIABETES, 2015, 64 : A21 - A21
  • [26] Renal Effects of Metformin in Type 1 Diabetes (T1D): The REMOVAL Trial
    Timmons, Joseph G.
    Greenlaw, Nicola
    Stehouwer, Coen D.
    Brouwers, Martijn
    Chaturvedi, Nishi
    Hughes, Alun D.
    Hramiak, Irene
    Jenkins, Alicia
    Welsh, Paul
    Sattar, Naveed
    Colhoun, Helen M.
    Rossing, Peter
    Petrie, John R.
    DIABETES, 2020, 69
  • [27] Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
    Maki Nakayama
    Norio Abiru
    Hiroaki Moriyama
    Naru Babaya
    Edwin Liu
    Dongmei Miao
    Liping Yu
    Dale R. Wegmann
    John C. Hutton
    John F. Elliott
    George S. Eisenbarth
    Nature, 2005, 435 : 220 - 223
  • [28] Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
    Nakayama, M
    Abiru, N
    Moriyama, H
    Babaya, N
    Liu, E
    Miao, DM
    Yu, LP
    Wegmann, DR
    Hutton, JC
    Elliott, JF
    Eisenbarth, GS
    NATURE, 2005, 435 (7039) : 220 - 223
  • [29] Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes
    Beales, PE
    Pozzilli, P
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (02) : 114 - 117
  • [30] Combination Therapy with IL-2 and Rapamycin Reverses Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice
    Ramiya, Vijayakumar
    Wasserfall, Clive
    Xue, Song
    Parker, Matthew
    Haller, Michael
    Schatz, Desmond
    Atkinson, Mark
    DIABETES, 2009, 58 : A87 - A87
12345